SecBot SecBot

INMD

InMode Ltd.
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. L3· CIK 0001742692 Healthcare & Medical Devices
$13.84 −0.14 (−0.97%)
Oct 26 4:00 PM ET · prev $13.97
Market cap
$807.6M
Small cap
Median target
$16.50
+19% · range $15.00–17.00
Next earnings
Nov 11
in 16 days · EPS est. $0.32
1 year
−11.6%
from $15.65 · Oct 27
30 days
−2.6%
from $14.20
52-week range
$12.76–16.62
−17% from high · low Mar 12
Avg volume 20D
460.6K
shares / day
Short interest
2.25M
≈3.9% of shares · −4.5%
Days to cover
5.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 2 bearish · 0 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 3/6 ·Next Earnings date, Nov 11, 2026
Strongest NEUTRAL InMode pre-announced Q3 2026 revenue of $91.8M-$92.0M, slightly above the $91.6M consensus, and reiterated…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 15 added (0 new), 17 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.338 → $0.322 over 90 days. 0 up, 3 down in 30 days.

  • Short sellersSTEADY

    Short interest −4.5% to 2.25M shares. 5.0 days to cover, ≈3.9% of shares.

  • TrendDOWNTREND

    5% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MILLENNIUM MANAGEMENT LLCADD1,751,972$25.6M
JPMORGAN CHASE & COADD560,496$8.3M
CITADEL ADVISORS LLCDOUBLED493,064$7.2M
GOLDMAN SACHS GROUP INCTRIM371,745$5.4M
SUSQUEHANNA INTERNATIONAL GROUP, LLPTRIM214,650$3.1M
AMERICAN CENTURY COMPANIES INCDOUBLED202,427$3.0M
CITIGROUP INCADD193,446$2.8M
D. E. Shaw & Co., Inc.TRIM116,726$1.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026
12-month targets · 3 analysts

Price is below the lowest target. Median implies +19%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
May 7, 2026Barclays
MAINTAIN
MAINTAINOverweight
May 7, 2026Baird
MAINTAIN
MAINTAINNeutral

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Aug 4, 2026
Itzkovich Moshe
Chief Financial Officer
AWARD14,000 sh
Jul 30, 2026
Ron Hadar
Director
AWARD2,000 sh
Jul 30, 2026
Kenneth Nadav
Director
AWARD2,000 sh
Jul 30, 2026
Nass Shlomo
Director
AWARD2,000 sh

Earnings setup

Estimates
Nov 11
reports in 16 days
$0.32
EPS estimate, this quarter
−5%
estimate change, 90 days
0↑ 3↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.32$0.28–$0.34+0.0%$90.8M
Next Q$0.38$0.37–$0.41+0.0%$101.1M
Current FY$1.30$1.23–$1.34+0.0%$370.3M
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
2,253,383
shares short
-4.5%
vs prior settlement
5.0
days to cover
≈3.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 21, 2026 SEC
Moshe Mizrahy filed Amendment No. 6 to his Schedule 13D on InMode Ltd., reporting a 7.90% beneficial ownership stake…
SC 13D/A — Impact 4/10
Oct 13, 2026 SEC
InMode pre-announced Q3 2026 revenue of $91.8M-$92.0M, slightly above the $91.6M consensus, and reiterated FY 2026…
PRESS-RELEASE — Impact 5/10
Oct 13, 2026 Earnings
InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
YOKNEAM, Israel, Oct. 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider
Aug 4, 2026 Insider
Itzkovich Moshe was granted 14,000 shares
Chief Financial Officer
Jul 30, 2026 Insider
Ron Hadar was granted 2,000 shares
Director
Jul 30, 2026 Insider
Kenneth Nadav was granted 2,000 shares
Director
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — ADD
1,751,972 shares ($25.6M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 11, 2026
Earnings date
INMD Q3 2026 Earnings Before Market Open — 2026-11-11
Recent
Oct 13, 2026
Earnings
InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
YOKNEAM, Israel, Oct. 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced…
Sep 9, 2026
Press release
InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
IRVINE, Calif., Sept. 9, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announces…
Aug 5, 2026
Earnings
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025
YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies…
Aug 5, 2026
Earnings date
INMD Q2 2026 Earnings Before Market Open — 2026-08-05
Jul 31, 2026
Short interest
Short Interest: INMD down 22% to 2.3M shares
Settlement 2026-07-31 | Days to cover: 4.01 | ≈3.68% of shares outstanding (est.)

SecBot reports

11 filings · 2 bullish · 4 bearish · 5 neutral
All INMD filing & press-release reports (11)